In support of our mission to be an international leader in developing, incubating, and commercializing medical technology, CCI partners with state and federal agencies to operate the multi-institutional Global Cardiovascular Innovation Center (GCIC)
and the NIH Center for Accelerated Innovations at Cleveland Clinic (NCAI-CC)
. Through these Centers, promising projects and companies can receive industry-experienced guidance to advance their technology towards commercialization.
The Global Cardiovascular Innovation Center (GCIC) is a cardiovascular product development consortium made possible through a $60 million grant from the State of Ohio’s Third Frontier Program. Founded in 2007, GCIC is the first Wright Mega-Center of Innovation under this program.
GCIC is focused on the formation, attraction, expansion and retention of cardiovascular companies to create jobs and facilitate economic development in the State of Ohio.
To learn more about GCIC, visit their website here.
Cleveland Clinic and its partners Case Western Reserve University, The Ohio State University, University of Cincinnati and Cincinnati Children’s, have established the National Center for Accelerated Innovation (NCAI), a center that will significantly increase the generation of new, patient benefiting products related to priority targets set by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH).
Cleveland Clinic and the NCAI’s institutional partners will present a steady stream of project development opportunities reflected by the base of nearly 250 on going NHLBI-funded research projects. These projects, along with innovations being generated at each of the participating institutions, will provide the initial focus for investigator engagement, technology solicitation, technology selection and technology development. Emphasizing innovations that fall within the domain of programs supported by NHLBI, selected projects will span diagnostics, devices, therapeutics and tools, and represent the full range of heart, lung, and blood disease areas, as well as related sleep disorders.
The Center is implementing broad-based, sustained activities, tools, and communication programs to reach out to investigators early in the life of technologies. Its technology solicitation and selection processes emphasize the criteria of clinical need, commercialization opportunity, and efficient project planning and will rapidly establish and maintain a robust pipeline of high-impact technology development opportunities for the Center.
To learn more about NCAI-CC, visit their website here.